Insider Transactions in Q1 2024 at Arvinas, Inc. (ARVN)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Noah Berkowitz Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,452
+50.0%
|
-
|
|
Feb 23
2024
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,702
-0.93%
|
$79,994
$47.05 P/Share
|
|
Feb 23
2024
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
5,196
-0.5%
|
$244,212
$47.05 P/Share
|
|
Feb 23
2024
|
John G Houston President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
124,450
+10.67%
|
-
|
|
Feb 23
2024
|
David K Loomis Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+40.35%
|
-
|
|
Feb 23
2024
|
Ian Taylor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,701
-1.14%
|
$79,947
$47.05 P/Share
|
|
Feb 23
2024
|
Ian Taylor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,250
+20.83%
|
-
|
|
Feb 23
2024
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,699
-2.45%
|
$79,853
$47.05 P/Share
|
|
Feb 23
2024
|
Ronald Peck Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,250
+36.19%
|
-
|
|
Jan 04
2024
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,252
+6.98%
|
$132,032
$16.0 P/Share
|